PMID- 29487073 OWN - NLM STAT- MEDLINE DCOM- 20180906 LR - 20190202 IS - 2044-6055 (Electronic) IS - 2044-6055 (Linking) VI - 8 IP - 2 DP - 2018 Feb 27 TI - Electroacupuncture for poststroke spasticity (EAPSS): protocol for a randomised controlled trial. PG - e017912 LID - 10.1136/bmjopen-2017-017912 [doi] LID - e017912 AB - INTRODUCTION: Spasticity is a common complication of stroke. Current therapies for poststroke spasticity (PSS) have been reported to be associated with high costs, lack of long-term benefit and unwanted adverse events (AEs). Electroacupuncture (EA) has been used for PSS, however, its efficacy and safety is yet to be confirmed by high-quality clinical studies. This study is designed to evaluate the add-on effects and safety profile of EA when used in combination with usual care (UC). METHODS AND ANALYSIS: This study is a parallel group randomised controlled trial. A total of 136 participants will be included and randomly assigned to either the treatment group (EA plus UC) or the control group (UC alone). Prior to the main trial, a pilot study involving 30 participants will be conducted to assess the feasibility of the trial protocol. EA will be administered by registered acupuncturists for 20min to 30 min, three times per week for 4 weeks. The primary outcome measure (Modified Ashworth Scale) and secondary outcome measures (Fugl-Meyer Assessment and Barthel Index) will be evaluated at baseline, the end of treatment (week 4) and the end of follow-up (week 8). AEs will be monitored, recorded and reported, and their causality will be explored. ETHICS AND DISSEMINATION: Ethics approval was obtained from the ethics committees of Guangdong Provincial Hospital of Chinese Medicine and RMIT University in December 2016. The results will be disseminated in a peer-reviewed journal, and PhD theses and might be presented at international conferences. TRIAL REGISTRATION NUMBER: ChiCTR-IOR-16010283; Pre-results. CI - (c) Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. FAU - Cai, Yiyi AU - Cai Y AD - Guangdong Provincial Hospital of Chinese Medicine (The Second Affiliated Hospital of Guangzhou University of Chinese Medicine), Guangdong Provincial Academy of Chinese Medical Sciences and The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. AD - China-Australia International Research Centre for Chinese Medicine, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia. FAU - Zhang, Claire Shuiqing AU - Zhang CS AUID- ORCID: 0000-0003-3866-602X AD - China-Australia International Research Centre for Chinese Medicine, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia. FAU - Ouyang, Wenwei AU - Ouyang W AD - Guangdong Provincial Hospital of Chinese Medicine (The Second Affiliated Hospital of Guangzhou University of Chinese Medicine), Guangdong Provincial Academy of Chinese Medical Sciences and The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. FAU - Li, Jianmin AU - Li J AD - Guangdong Provincial Hospital of Chinese Medicine (The Second Affiliated Hospital of Guangzhou University of Chinese Medicine), Guangdong Provincial Academy of Chinese Medical Sciences and The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. FAU - Nong, Wenheng AU - Nong W AD - Guangdong Provincial Hospital of Chinese Medicine (The Second Affiliated Hospital of Guangzhou University of Chinese Medicine), Guangdong Provincial Academy of Chinese Medical Sciences and The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. FAU - Zhang, Anthony Lin AU - Zhang AL AD - China-Australia International Research Centre for Chinese Medicine, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia. FAU - Xue, Charlie Changli AU - Xue CC AD - Guangdong Provincial Hospital of Chinese Medicine (The Second Affiliated Hospital of Guangzhou University of Chinese Medicine), Guangdong Provincial Academy of Chinese Medical Sciences and The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. AD - China-Australia International Research Centre for Chinese Medicine, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia. FAU - Wen, Zehuai AU - Wen Z AD - Guangdong Provincial Hospital of Chinese Medicine (The Second Affiliated Hospital of Guangzhou University of Chinese Medicine), Guangdong Provincial Academy of Chinese Medical Sciences and The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. LA - eng PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20180227 PL - England TA - BMJ Open JT - BMJ open JID - 101552874 SB - IM MH - *Electroacupuncture MH - Humans MH - Muscle Spasticity/*therapy MH - Pilot Projects MH - Research Design MH - Safety MH - Severity of Illness Index MH - Stroke/*complications MH - Treatment Outcome PMC - PMC5855476 OTO - NOTNLM OT - acupuncture OT - muscle spasticity OT - randomised controlled trial OT - stroke COIS- Competing interests: None declared. EDAT- 2018/03/01 06:00 MHDA- 2018/09/07 06:00 PMCR- 2018/02/27 CRDT- 2018/03/01 06:00 PHST- 2018/03/01 06:00 [entrez] PHST- 2018/03/01 06:00 [pubmed] PHST- 2018/09/07 06:00 [medline] PHST- 2018/02/27 00:00 [pmc-release] AID - bmjopen-2017-017912 [pii] AID - 10.1136/bmjopen-2017-017912 [doi] PST - epublish SO - BMJ Open. 2018 Feb 27;8(2):e017912. doi: 10.1136/bmjopen-2017-017912.